Status:
UNKNOWN
GENETIC BASIS of LEFT VENTRICULAR APICAL HYPOPLASIA
Lead Sponsor:
Monaldi Hospital
Collaborating Sponsors:
Bambino Gesù Hospital and Research Institute
Conditions:
Left Ventricular Apical Hypoplasia (LVAH), New Rare Condition
Eligibility:
All Genders
Up to 90 years
Brief Summary
Brief summary Left ventricular apical hypoplasia (LVAH) is a rare cardiomyopathy characterized by a spherical, truncated LV with some degree of systolic dysfunction, an elongated, normally functioning...
Eligibility Criteria
Inclusion
- Male and female patients, 0-90 years old, in any distribution.
- Patients who have the diagnostic criteria for LVAH. Diagnosis of LVAH is based on echocardiographic or cardiac magnetic resonance (CMR) evidence of all the following diagnostic criteria:
- a spherical, truncated LV with some degree of systolic dysfunction;
- an elongated, normally functioning right ventricle that wraps around the distal left ventricle;
- deficiency of the myocardium within the LV apex with adipose tissue infiltrating the apex;
- origin of the papillary muscle in the flattened anterior apex.
Exclusion
- Involvement with any other ongoing studies.
- Patients who have diagnosis of other Cardiomyopathies
Key Trial Info
Start Date :
September 20 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2023
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT04339582
Start Date
September 20 2013
End Date
March 1 2023
Last Update
April 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ospedale V. Monaldi, Università degli studi della Campania, Luigi Vanvitelli
Naples, Italy, 80121